vs

Side-by-side financial comparison of SES AI Corp (SES) and Wave Life Sciences Ltd. (WVE). Click either name above to swap in a different company.

Wave Life Sciences Ltd. is the larger business by last-quarter revenue ($8.7M vs $4.6M, roughly 1.9× SES AI Corp). SES AI Corp runs the higher net margin — -373.5% vs -580.2%, a 206.7% gap on every dollar of revenue. SES AI Corp produced more free cash flow last quarter ($-11.1M vs $-46.3M).

SES S.A. is a Luxembourgish communications satellite operator supplying video and data connectivity worldwide to broadcasters, content and internet service providers, mobile and fixed network operators, governments and institutions.

BIT Life Sciences is a for profit meetings, incentives, conferencing, exhibitions (MICE) company based in Dalian, China, that specializes in arranging multiple scientific congresses that have been described as "predatory". The company is part of a wave of organizations that have appeared in China in the past several years noted for arranging congresses with little academic merit and with the primary aim of generating revenue rather than scientific knowledge sharing. Papers submitted are usual...

SES vs WVE — Head-to-Head

Bigger by revenue
WVE
WVE
1.9× larger
WVE
$8.7M
$4.6M
SES
Higher net margin
SES
SES
206.7% more per $
SES
-373.5%
-580.2%
WVE
More free cash flow
SES
SES
$35.2M more FCF
SES
$-11.1M
$-46.3M
WVE

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
SES
SES
WVE
WVE
Revenue
$4.6M
$8.7M
Net Profit
$-17.0M
$-50.5M
Gross Margin
11.3%
Operating Margin
-387.7%
-606.5%
Net Margin
-373.5%
-580.2%
Revenue YoY
-55.8%
Net Profit YoY
50.7%
-53.3%
EPS (diluted)
$-0.05
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SES
SES
WVE
WVE
Q4 25
$4.6M
Q3 25
$7.1M
Q2 25
$3.5M
$8.7M
Q1 25
$5.8M
$9.2M
Q2 24
$19.7M
Q1 24
$12.5M
Q4 23
$29.1M
Q3 23
$49.2M
Net Profit
SES
SES
WVE
WVE
Q4 25
$-17.0M
Q3 25
$-20.9M
Q2 25
$-22.7M
$-50.5M
Q1 25
$-12.4M
$-46.9M
Q2 24
$-32.9M
Q1 24
$-31.6M
Q4 23
$-16.3M
Q3 23
$7.3M
Gross Margin
SES
SES
WVE
WVE
Q4 25
11.3%
Q3 25
51.1%
Q2 25
73.7%
Q1 25
78.7%
Q2 24
Q1 24
Q4 23
Q3 23
Operating Margin
SES
SES
WVE
WVE
Q4 25
-387.7%
Q3 25
-262.0%
Q2 25
-652.3%
-606.5%
Q1 25
-401.7%
-542.8%
Q2 24
-177.7%
Q1 24
-274.8%
Q4 23
-64.3%
Q3 23
9.0%
Net Margin
SES
SES
WVE
WVE
Q4 25
-373.5%
Q3 25
-293.9%
Q2 25
-642.2%
-580.2%
Q1 25
-214.6%
-510.9%
Q2 24
-167.2%
Q1 24
-251.7%
Q4 23
-55.9%
Q3 23
14.7%
EPS (diluted)
SES
SES
WVE
WVE
Q4 25
$-0.05
Q3 25
$-0.06
Q2 25
$-0.07
$-0.31
Q1 25
$-0.04
$-0.29
Q2 24
$-0.25
Q1 24
$-0.24
Q4 23
$-0.14
Q3 23
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SES
SES
WVE
WVE
Cash + ST InvestmentsLiquidity on hand
$29.5M
$208.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$214.8M
$139.3M
Total Assets
$272.6M
$252.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SES
SES
WVE
WVE
Q4 25
$29.5M
Q3 25
$35.3M
Q2 25
$11.8M
$208.5M
Q1 25
$56.1M
$243.1M
Q2 24
$154.0M
Q1 24
$180.9M
Q4 23
$200.4M
Q3 23
$139.9M
Stockholders' Equity
SES
SES
WVE
WVE
Q4 25
$214.8M
Q3 25
$228.2M
Q2 25
$249.2M
$139.3M
Q1 25
$269.9M
$171.8M
Q2 24
$-3.5M
Q1 24
$25.4M
Q4 23
$39.6M
Q3 23
$-40.5M
Total Assets
SES
SES
WVE
WVE
Q4 25
$272.6M
Q3 25
$288.8M
Q2 25
$290.5M
$252.4M
Q1 25
$306.0M
$288.3M
Q2 24
$208.8M
Q1 24
$235.3M
Q4 23
$274.9M
Q3 23
$199.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SES
SES
WVE
WVE
Operating Cash FlowLast quarter
$-10.4M
$-46.0M
Free Cash FlowOCF − Capex
$-11.1M
$-46.3M
FCF MarginFCF / Revenue
-243.7%
-532.5%
Capex IntensityCapex / Revenue
15.6%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-61.2M
$-170.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SES
SES
WVE
WVE
Q4 25
$-10.4M
Q3 25
$-14.3M
Q2 25
$-10.8M
$-46.0M
Q1 25
$-22.8M
$-63.0M
Q2 24
$-27.5M
Q1 24
$-33.4M
Q4 23
$-33.2M
Q3 23
$-34.5M
Free Cash Flow
SES
SES
WVE
WVE
Q4 25
$-11.1M
Q3 25
$-14.7M
Q2 25
$-11.6M
$-46.3M
Q1 25
$-23.7M
$-63.2M
Q2 24
$-27.5M
Q1 24
$-33.8M
Q4 23
$-33.6M
Q3 23
$-34.7M
FCF Margin
SES
SES
WVE
WVE
Q4 25
-243.7%
Q3 25
-206.9%
Q2 25
-329.6%
-532.5%
Q1 25
-410.0%
-688.9%
Q2 24
-139.8%
Q1 24
-270.0%
Q4 23
-115.6%
Q3 23
-70.4%
Capex Intensity
SES
SES
WVE
WVE
Q4 25
15.6%
Q3 25
6.0%
Q2 25
22.8%
3.5%
Q1 25
15.8%
1.8%
Q2 24
0.3%
Q1 24
3.3%
Q4 23
1.2%
Q3 23
0.4%
Cash Conversion
SES
SES
WVE
WVE
Q4 25
Q3 25
Q2 25
Q1 25
Q2 24
Q1 24
Q4 23
Q3 23
-4.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons